Stock Market Today: Dow Jumps 482 Points on Promising Merck Data
The blue-chip drugmaker reported positive results for its oral COVID-19 treatment, developed alongside Ridgeback Biotherapeutics.
It was a choppy start to the first day of a new month and quarter, with stocks displaying weakness at the open.
However, the major market indexes turned higher after the Institute for Supply Management's (ISM) manufacturing index – a measure of factory activity – came in at a higher-than-anticipated 61.1 in September, and the University of Michigan's consumer sentiment index for the same month also beat the consensus estimate (72.8 actual vs. 71.0 expected).
The Dow Jones Industrial Average easily outperformed its peers, adding 1.4% to 34,326, on strength from Merck (MRK, +8.4%).
Sign up for Kiplinger’s Free E-Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
The drugmaker got a big boost after late-stage data showed its antiviral pill, co-developed with Ridgeback Biotherapeutics, reduced the chance of death or hospitalizations by around 50% in high-risk COVD-19 patients. The firms plan to submit the results to the Food and Drug Administration (FDA) for emergency authorization.
The S&P 500 Index gained 1.2% to 4,357 and the Nasdaq Composite rose 0.8% to 14,566.
Other news in the stock market today:
- The small-cap Russell 2000 surged 1.7% to 2,241.
- Several makers of COVID-19 vaccines fell in reaction to the promising data from Merck. Moderna (MRNA) gave back 11.4%, Regeneron Pharmaceutials (REGN) fell 5.7% and BioNTech (BNTX) slumped 6.7%.
- Lordstown Motors (RIDE) was also a notable decliner today, sliding 18.3%. This came after the electric vehicle (EV) maker late Thursday said it agreed in principle to sell its Ohio-based assembly plant to iPhone maker Foxconn for $230 million. As part of the deal, Foxconn will manufacture the vehicle maker's all-electric pickup truck and purchase roughly $50 million of RIDE common stock. Lordstown, meanwhile, will now be able to focus its efforts on bringing the vehicle to market, said CEO Daniel Ninivaggi in a statement.
- U.S. crude oil futures rose 1.1% to finish at $75.88 per barrel.
- Gold futures eked out a marginal gain to settle at $1,758.40 an ounce.
- The CBOE Volatility Index (VIX) spiraled 8.6% to 21.15.
- Bitcoin prices gained 10.4% to $48,071.09. "Today's spike is directly correlated to news out of Washington," says Charlie Silver, CEO of Permission.io, a cryptocurrency-enabled provider of e-commerce permission advertising. "Most importantly in direct opposition to recent Chinese announcements, Fed Chair Jerome Powell made it clear that the dollar can coexist with cryptocurrencies. In addition, all the discussion around eliminating the debt ceiling also fuels the animal spirits in crypto." (Bitcoin trades 24 hours a day; prices reported here are as of 4 p.m. each trading day.)
Don't Let October Scare You
You wouldn't know it by today's action, but October can be pretty spooky for stocks.
"October is known for some spectacular crashes and many expect bad things to happen again this year," says Ryan Detrick, chief market strategist for LPL Financial. "No month has seen more 1% moves (up or down) than October, with some of the largest one-day moves (both up and down) taking place this month."
And with the S&P 500 failing to have a 5% pullback yet this year – it came close with its 4.8% September decline – it's understandable if investors are skittish.
However, Detrick notes that the fourth quarter is historically bullish for stocks, so if we do see any more weakness, it should be used as an opportunity "to add to core positions."
There are plenty of options for investors who may want to put together their wish list now, including these high dividend payers or these sturdy blue chips. There's also our Kiplinger 25, which is perfect for investors looking to build a core portfolio. This list of 25 mutual funds offer easy diversification across a wide range of issues, and they all have solid long-term records with attractively low fees. Check them out.
Get Kiplinger Today newsletter — free
Profit and prosper with the best of Kiplinger's advice on investing, taxes, retirement, personal finance and much more. Delivered daily. Enter your email in the box and click Sign Me Up.
With over a decade of experience writing about the stock market, Karee Venema is the senior investing editor at Kiplinger.com. She joined the publication in April 2021 after 10 years of working as an investing writer and columnist at Schaeffer's Investment Research. In her previous role, Karee focused primarily on options trading, as well as technical, fundamental and sentiment analysis.
-
Four Ways to Invest in Quantum Computing
Quantum computing offers mind-boggling problem-solving potential. Here are four ways to buy quantum computing stocks.
By Tom Taulli Published
-
Stock Market Today: Earnings and AI Send Stocks to New Highs
A massive investment in artificial intelligence and upbeat earnings pushed equities to record levels.
By Dan Burrows Published
-
Stock Market Today: Dow Leads as UnitedHealth Stock Pops
UnitedHealth was the best Dow Jones stock Monday on reports that Medicare Advantage payments could rise in 2026.
By Karee Venema Published
-
Stock Market Today: Stocks End Mixed After FOMC Minutes
The minutes from the December Fed meeting signaled central bankers' uncertainty over potential Trump administration policies.
By Karee Venema Published
-
Moderna Stock Is Volatile Amid Bird Flu Developments
Moderna stock has been volatile this week as the first death in the U.S. connected to bird flu was reported. Here's what you need to know.
By Joey Solitro Published
-
Stock Market Today: Stocks Are Mixed Ahead of the Fed
Two of the three main equity indexes closed higher on the first day of the final Fed Week of 2024.
By David Dittman Published
-
Why Is Warren Buffett Selling So Much Stock?
Berkshire Hathaway is dumping equities, hoarding cash and making market participants nervous.
By Dan Burrows Published
-
If You'd Put $1,000 Into Google Stock 20 Years Ago, Here's What You'd Have Today
Google parent Alphabet has been a market-beating machine for ages.
By Dan Burrows Published
-
Stock Market Today: Stocks Rise in Choppy Day for Markets
Moderna was the worst S&P 500 stock today after the vaccine maker slashed its R&D budget.
By Karee Venema Published
-
Moderna Stock Plunges as Vaccine Maker Slashes R&D Budget: What to Know
Moderna stock is plunging Thursday after the COVID-19 vaccine maker announced plans to drastically cut its R&D spending to focus on new product approvals.
By Joey Solitro Published